JP2006052172A5 - - Google Patents

Download PDF

Info

Publication number
JP2006052172A5
JP2006052172A5 JP2004235253A JP2004235253A JP2006052172A5 JP 2006052172 A5 JP2006052172 A5 JP 2006052172A5 JP 2004235253 A JP2004235253 A JP 2004235253A JP 2004235253 A JP2004235253 A JP 2004235253A JP 2006052172 A5 JP2006052172 A5 JP 2006052172A5
Authority
JP
Japan
Prior art keywords
derivatives
pyrazolone
phenyl
methyl
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004235253A
Other languages
English (en)
Japanese (ja)
Other versions
JP4746856B2 (ja
JP2006052172A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004235253A priority Critical patent/JP4746856B2/ja
Priority claimed from JP2004235253A external-priority patent/JP4746856B2/ja
Publication of JP2006052172A publication Critical patent/JP2006052172A/ja
Publication of JP2006052172A5 publication Critical patent/JP2006052172A5/ja
Application granted granted Critical
Publication of JP4746856B2 publication Critical patent/JP4746856B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004235253A 2004-08-12 2004-08-12 ピラゾロン系製剤 Expired - Fee Related JP4746856B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004235253A JP4746856B2 (ja) 2004-08-12 2004-08-12 ピラゾロン系製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004235253A JP4746856B2 (ja) 2004-08-12 2004-08-12 ピラゾロン系製剤

Publications (3)

Publication Number Publication Date
JP2006052172A JP2006052172A (ja) 2006-02-23
JP2006052172A5 true JP2006052172A5 (https=) 2007-09-27
JP4746856B2 JP4746856B2 (ja) 2011-08-10

Family

ID=36029873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004235253A Expired - Fee Related JP4746856B2 (ja) 2004-08-12 2004-08-12 ピラゾロン系製剤

Country Status (1)

Country Link
JP (1) JP4746856B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101678112B (zh) * 2007-01-19 2016-08-31 哈南亚有限公司 用于递送治疗剂的方法和组合物
WO2009041714A1 (ja) * 2007-09-26 2009-04-02 Mikasa Seiyaku Co., Ltd. フリーラジカル性疾患用外用剤
JP5509090B2 (ja) * 2007-11-21 2014-06-04 テイコク ファーマ ユーエスエー インコーポレーテッド ピラゾロン誘導体のエマルジョン製剤
CN101524352A (zh) 2008-03-04 2009-09-09 江苏先声药物研究有限公司 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物
CN101953832B (zh) * 2010-08-10 2012-02-15 南京师范大学 β-环糊精包合依达拉奉的口服药物组合物及其制备方法
US8791269B2 (en) * 2011-07-01 2014-07-29 Fondazione Istituto Insubrico Di Ricerca Per La Vita Complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof
WO2019073052A1 (en) * 2017-10-13 2019-04-18 Treeway Tw001 B.V. EDARAVONE SALT
GB202103807D0 (en) * 2021-03-18 2021-05-05 Johnson Matthey Plc A crystalline salt of edaravone, processes for the preparation and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2906512B2 (ja) * 1990-01-16 1999-06-21 三菱化学株式会社 抗潰瘍剤
JP3176716B2 (ja) * 1991-06-21 2001-06-18 武田薬品工業株式会社 溶解性が向上した難水溶性薬物組成物
DE4333598A1 (de) * 1993-10-01 1995-04-06 Consortium Elektrochem Ind Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten, nach dem Verfahren herstellbare methylierte Cyclodextrin-Derivate und die Verwendung der Produkte
JPH10279480A (ja) * 1997-04-07 1998-10-20 Mitsubishi Chem Corp 皮膚組織障害の予防・治療剤
CN1525856A (zh) * 2001-05-11 2004-09-01 三菱制药株式会社 含吡唑啉酮衍生物的稳定的高浓度注射剂
JP2003081830A (ja) * 2001-09-12 2003-03-19 Mitsubishi-Tokyo Pharmaceuticals Inc 酸化ストレス抑制剤
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
JP2004300153A (ja) * 2003-03-20 2004-10-28 Kiyoshi Kurokawa 蛋白修飾物生成抑制剤

Similar Documents

Publication Publication Date Title
US5646131A (en) Method for solubilizing drugs using cyclodextrins and carboxylic acids
Salústio et al. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release
RU2591804C2 (ru) Композиции бендамустина и циклополисахарида
Sharma et al. Development of taste masked film of valdecoxib for oral use.
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
JP2002332234A (ja) ボリコナゾールを含有する薬剤製剤
JP5412709B2 (ja) 改良された経口及び経粘膜デリバリーのためのクラドリビン製剤
CN1223347C (zh) 注射用西洛他唑水性制剂
JP2008526757A5 (https=)
JPWO1999061061A1 (ja) 薬物複合体
JP2008505902A5 (https=)
CN103037903A (zh) 用于治疗自身免疫性疾病或其它疾病的组合物和方法
JP2010132681A (ja) 向上した薬物動態特性を有する組成物
WO2004089418A1 (en) A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid
JP2006052172A5 (https=)
NZ237583A (en) Preparation of piroxicam - cyclodextrin complexes and pharmaceutical compositions thereof
JP2006219501A (ja) 懸濁形態でのアリール複素環活性薬物の蓄積製剤
BRPI0311511B1 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
US20090074874A1 (en) Process for Producing Polymer Micelles Encapsulating Low Molecular Weight Drugs
US9284341B2 (en) Rapidly dissolving pharmaceutical composition
JP2003504312A5 (https=)
Fenyvesi et al. Controlled release of drugs from CD polymers substituted with ionic groups
JP2006052172A (ja) ピラゾロン系製剤
TW200914028A (en) Pirenoxine contented two liquid applying eye drop medicine
KR20060129289A (ko) 이트라코나졸을 유효성분으로 하는 약학적 조성물